BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months

Biotech catalysts in 2026-04

174 industry Phase 2/3 trial readout(s) and 33 FDA decision event(s). Readouts include completed (ACTUAL) and still-estimated primary completion dates in this month, any status.

← 2026-03 | 2026-05 →

FDA decision events

DateEventStatusCompanyDrugSource
2026-04-01FDA approvalapprovedELI LILLY AND CO LLYFOUNDAYOApproved 2026-04-01: FOUNDAYO (NDA220934 ORIG1)
2026-04-01 (quarter)PDUFA date (company-disclosed)date passedMineralys Therapeutics, Inc. MLYSPDUFA second quarter of 2026 - Mineralys Therapeutics, Inc.
2026-04-02FDA approvalapprovedREGENERON PHARMACEUTICALS REGNEYLEA HDApproved 2026-04-02: EYLEA HD (BLA761355 SUPPL5)
2026-04-09FDA approvalapprovedBRISTOL BMYONUREGApproved 2026-04-09: ONUREG (NDA214120 SUPPL3)
2026-04-09FDA approvalapprovedGENENTECH INCVABYSMOApproved 2026-04-09: VABYSMO (BLA761235 SUPPL8)
2026-04-10Complete response lettercomplete responseTelix Pharmaceuticals (US) Inc. TLX8°Zr-TLX250CRL 2026-04-10: Telix Pharmaceuticals (US) Inc. BLA 761401 (8°Zr-TLX250)
2026-04-10Complete response lettercomplete responseReplimune, Inc. REPLCRL 2026-04-10: Replimune, Inc. BL 125827
2026-04-13Complete response lettercomplete responseEagle Pharmaceuticals, Inc. EXPFulvestrantCRL 2026-04-13: Eagle Pharmaceuticals, Inc. NDA 220045 (Fulvestrant Injection)
2026-04-13FDA approvalapprovedTRAVERE TVTXFILSPARIApproved 2026-04-13: FILSPARI (NDA216403 SUPPL6)
2026-04-15FDA approvalapprovedGENENTECH INCITOVEBIApproved 2026-04-15: ITOVEBI (NDA219249 SUPPL4)
2026-04-15FDA approvalapprovedJANSSEN BIOTECHSTELARAApproved 2026-04-15: STELARA (BLA761044 SUPPL20)
2026-04-15FDA approvalapprovedASTRAZENECA AB AZNWAINUAApproved 2026-04-15: WAINUA; WAINUA (AUTOINJECTOR) (NDA217388 SUPPL5)
2026-04-17FDA approvalapprovedNOVARTIS PHARMS CORP NVSCOSENTYXApproved 2026-04-17: COSENTYX (BLA125504 SUPPL97)
2026-04-17FDA approvalapprovedNOVARTIS PHARMS CORP NVSCOSENTYXApproved 2026-04-17: COSENTYX (BLA125504 SUPPL98)
2026-04-20FDA approvalapprovedPROVENTION BIO INCTZIELDApproved 2026-04-20: TZIELD (BLA761183 SUPPL13)
2026-04-20FDA approvalapprovedMSDIDVYNSOApproved 2026-04-20: IDVYNSO (NDA216964 ORIG1)
2026-04-22Complete response lettercomplete responseAbbVie Inc. ABBVAGN-151586CRL 2026-04-22: AbbVie Inc. BLA 761459 (AGN-151586 for injection)
2026-04-22FDA approvalapprovedREGENERON PHARMACEUTICALS REGNDUPIXENTApproved 2026-04-22: DUPIXENT (BLA761055 SUPPL74)
2026-04-23Complete response lettercomplete responseGrace Therapeutics U.S., Inc. GRCE(nimodipine) injectionCRL 2026-04-23: Grace Therapeutics U.S., Inc. NDA 220304 ((nimodipine) injection)
2026-04-23FDA approvalapprovedKARYOPHARM THERAPS KPTIQXPOVIOApproved 2026-04-23: XPOVIO (NDA212306 SUPPL18)
2026-04-23FDA approvalapprovedGENENTECHPERJETAApproved 2026-04-23: PERJETA (BLA125409 SUPPL141)
2026-04-23FDA approvalapprovedKYOWA KIRINCRYSVITAApproved 2026-04-23: CRYSVITA (BLA761068 SUPPL11)
2026-04-24FDA approvalapprovedINTRA-CELLULARCAPLYTAApproved 2026-04-24: CAPLYTA (NDA209500 SUPPL17)
2026-04-24FDA approvalapprovedASTRAZENECA AB AZNSAPHNELOApproved 2026-04-24: SAPHNELO (BLA761451 ORIG1)
2026-04-24FDA approvalapprovedMERCK SHARP DOHME MRKKEYTRUDA QLEXApproved 2026-04-24: KEYTRUDA QLEX (BLA761467 SUPPL3)
2026-04-27FDA approvalapprovedASTRAZENECA AZNSYMBICORT AEROSPHEREApproved 2026-04-27: SYMBICORT AEROSPHERE (NDA216579 SUPPL1)
2026-04-27FDA approvalapprovedACADIA PHARMS INC ACADNUPLAZIDApproved 2026-04-27: NUPLAZID (NDA207318 SUPPL16)
2026-04-27FDA approvalapprovedASTRAZENECA AB AZNBREZTRI AEROSPHEREApproved 2026-04-27: BREZTRI AEROSPHERE (NDA212122 SUPPL9)
2026-04-27FDA approvalapprovedACADIA PHARMS INC ACADNUPLAZIDApproved 2026-04-27: NUPLAZID (NDA210793 SUPPL14)
2026-04-27FDA approvalapprovedDAIICHI SANKYOENHERTUApproved 2026-04-27: ENHERTU (BLA761139 SUPPL39)
2026-04-29FDA approvalapprovedSUNSHINE LAKE PHARMA CO LTD SBFMLANGLARAApproved 2026-04-29: LANGLARA (BLA761412 ORIG1)
2026-04-30FDA AdComheldAstraZeneca Pharmaceuticals LP AZNAdCom 2026-04-30: Oncologic Drugs Advisory Committee - NDA 220359, sNDA 218197/S-004
2026-04-30FDA approvalapprovedAXSOME AXSMAUVELITYApproved 2026-04-30: AUVELITY (NDA215430 SUPPL18)

Trial readouts

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2026-04 est.P1/P2Ascentage Pharma Group Inc. AAPGNCT04785196 APG-115 in Combination With PD-1 Inhibitor in Patients With Advanced Liposarcoma or Advanced Solid TumorsLiposarcoma; Advanced Solid Tumorrecruiting95
2026-04 est.P2Scientific Center for Anti-infectious Drugs, KazakhstanNCT05060705 "Efesovir" (FS-1) for COVID-19, Phase 2Covid19not yet recruiting62
2026-04 est.P2aTyr Pharma, Inc. ATYRNCT05892614 Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-IInterstitial Lung Diseaserecruiting25
2026-04 est.P1/P2Ascentage Pharma Group Inc. AAPGNCT06182969 A Study of APG-2575 in Patients With Mild-to-moderate Systemic Lupus Erythematosus.SLErecruiting40
2026-04 est.P3Suzhou Suncadia Biopharmaceuticals Co., Ltd.NCT06199973 Injection of SHR-A1811 Versus Physician Choiced Treatment in Patients With Advanced Colorectal Cancer Who Had Failed to Respond to Oxaliplatin, 5-fu, and IrinotAdvanced Colorectal Canceractive not recruiting130
2026-04 est.P3Insud PharmaNCT06282315 Real World Evaluation of an Albendazole-Ivermectin Coformulation Safety and EffectivenessSoil-Transmitted Helminthsrecruiting20000
2026-04 est.P1/P2AkesoNCT06387420 A Study of AK117 in Combination With Azactidine Plus Venetoclax in Patients With Acute Myeloid LeukemiaACUTE MYELOID LEUKEMIA; AMLnot yet recruiting180
2026-04 est.P2/P3Guangzhou Ruianbo Pharmaceutical Technology Co., LtdNCT06603142 Phase II/III Study of AR882 Capsules Compared to Febuxostat Tablets in Patients with Primary Gout and HyperuricemiaPrimary Gout; Hyperuricemiaunknown636
2026-04 est.P3JW PharmaceuticalNCT06643130 Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and DyslipidemiaHypertension; Dyslipidemiarecruiting162
2026-04 est.P3Qilu Pharmaceutical Co., Ltd.NCT06649214 A Study of Olanzapine-Samidorphan Tablets in Adults With SchizophreniaSchizophreniaunknown654
2026-04 est.P2Odyssey Therapeutics, Inc. ODTXNCT06850727 Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative ColitisUlcerative Colitis (UC); UC - Ulcerative Colitisrecruiting57
2026-04 est.P1/P2Jiangsu HengRui Medicine Co., Ltd.NCT06925581 A Trial of HRS-6768 in Patients With Advanced Solid TumorsAdvanced Solid Tumorsrecruiting84
2026-04 est.P1/P2Mabwell (Shanghai) Bioscience Co., Ltd.NCT06947226 A Clinical Study of 9MW2821 Monotherapy or Combined With Other Anticancer Therapy in Advanced Solid TumorsSolid Tumorsnot yet recruiting188
2026-04 est.P2Staidson (Beijing) Biopharmaceuticals Co., LtdNCT06975748 A Phase II Study of STSP-0902 Ophthalmic Solution in Patients With Neurotrophic KeratitisNeurotrophic Keratitisrecruiting48
2026-04 est.P2Shenyang Sunshine Pharmaceutical Co., LTD.NCT07007936 Phase IIa Trial of Oral SSS17 for Post-Arthroplasty AnemiaPostoperative Anemia; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kneenot yet recruiting90
2026-04 est.P3Xuanzhu Biopharmaceutical Co., Ltd.NCT07010107 A Clinical Trial of Anaprazole for Treating Reflux Esophagitis.Reflux Esophagitis (RE)recruiting500
2026-04 est.P3Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT07036172 Efficacy and Safety of Semaglutide Injection Vs WEGOVY® in Chinese Obese PatientsObesity Controlrecruiting460
2026-04 est.P2Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.NCT07174115 A Study to Evaluate the Efficacy and Safety of HTMC0658 Tablets in the Treatment of Chronic Rhinosinusitis Without Nasal PolypsChronic Sinusitis Without Nasal Polypsrecruiting30
2026-04 est.P2Alixer Nexgen Therapeutics LimitedNCT07219849 A Study to Determine the Optimal Dose and Frequency of ALDP001 Nasal Spray in Adults With Seasonal Allergic Rhinitis Under Allergen ExposureSeasonal Allergic Rhinitis (SAR)recruiting164
2026-04-01 est.P1/P2Curis, Inc. CRISNCT04278768 Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)Acute Myelogenous Leukemia; Myelodysplastic Syndromesuspended366
2026-04-01 est.P3Jiangsu HengRui Medicine Co., Ltd.NCT04342910 Study to Evaluate the Efficacy and Safety of Camrelizumab and Apatinib in Patients With GC/GEJCGastric Cancerrecruiting550
2026-04-01P1/P2ModernaTX, Inc.NCT04899310 A Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of mRNA-3705 in Participants With Isolated Methylmalonic AcidemiaMethylmalonic Acidemiaterminated18
2026-04-01P2/P3Insmed Incorporated INSMNCT05649722 An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)Pulmonary Hypertension; Interstitial Lung Diseasecompleted31
2026-04-01P1/P2Praxis Precision Medicines PRAXNCT05737784 A Clinical Trial of PRAX-222 in Pediatric Participants With Early Onset SCN2A Developmental and Epileptic EncephalopathySCN2A-DEE; Epilepsyactive not recruiting60
2026-04-01 est.P3Protagonist Therapeutics, Inc. PTGXNCT06033586 Study to Evaluate the Long-term Safety of Rusfertide (PTG-300) in Subjects With Polycythemia VeraPolycythemia Veraactive not recruiting46
2026-04-01 est.P3Jiangsu Alphamab Biopharmaceuticals Co., LtdNCT06079983 JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer SubjectsBreast Cancerrecruiting400
2026-04-01P3Janssen Research & Development, LLCNCT06208150 A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Multiple Myelomaactive not recruiting838
2026-04-01P1/P2Theradaptive, IncNCT07078331 Safety and Performance, and Dose, of OsteoAdapt DE in Localized Alveolar Ridge AugmentationsTooth Extraction Site Healing; Ridge Augmentation; Bone Graftactive not recruiting45
2026-04-01 est.P1/P2ExoRNA BioscienceNCT07339514 A Phase I Clinical Study of ER2001 Injection for the Treatment of Early Manifest Huntington's Disease.Huntington Diseaseactive not recruiting27
2026-04-01P3Newsoara Biopharma Co., Ltd.NCT07712731 HPP737 in Adult Patients With Plaque PsoriasisPsoriasiscompleted607
2026-04-02P3Immunovant Sciences GmbH IMVTNCT05517447 Extension Study to Assess Batoclimab in Participants With Thyroid Eye DiseaseThyroid Eye Diseaseterminated109
2026-04-02P2Bial R&D Investments, S.A.NCT05819359 Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PDParkinson's Diseasecompleted273
2026-04-02P1/P2iOmx Therapeutics AGNCT05826600 A Study of OMX-0407 in Patients With Previously Treated Solid Tumours That Can't be Removed SurgicallySolid Tumorterminated68
2026-04-02P3Oculis OCSNCT06172257 A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 2)Diabetic Macular Edemacompleted401
2026-04-02P2Merck Sharp & Dohme LLC MRKNCT06956235 Study to Evaluate Tulisokibart for Hidradenitis Suppurativa (MK-7240-012)Hidradenitis Suppurativaactive not recruiting149
2026-04-02P2RDC Clinical Pty LtdNCT07412730 Glucose Tolerance StudyHealthy Volunteers; Glucose Tolerancecompleted19
2026-04-02P2Joincare Pharmaceutical Group Industry Co., LtdNCT07440524 A Phase 2 Trial of JKN24011 in COPDCOPD (Chronic Obstructive Pulmonary Disease)completed215
2026-04-03P3Arog Pharmaceuticals, Inc.NCT03250338 Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AMLRelapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating Mutationscompleted106
2026-04-03P3RemeGen Co., Ltd.NCT03330418 A Phase III Study of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Neuromyelitis Optica Spectrum DisordersNeuromyelitis Optica Spectrum Disordersterminated178
2026-04-03P2RemeGen Co., Ltd.NCT04625153 RC18 in Patients With Relapsing Remitting Multiple Sclerosis:a Phase II TrialMultiple Sclerosis, Relapsing-Remittingterminated8
2026-04-03P1/P2Sanofi SNYNCT06695130 Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and Recombinant InfCOVID-19 Immunization; Influenza Immunizationcompleted980
2026-04-03P3Ondine Biomedical Inc.NCT06702878 Light-Activated Antimicrobial Therapy to Prevent Surgical Site InfectionsSurgical Site Infections; Surgical Wound Infection; Infections; Anti-Infective Agentscompleted4787
2026-04-03P3AbbVie ABBVNCT06794866 A Study to Assess Adverse Events and Effectiveness of OnabotulinumtoxinA Intramuscular Injections for the Change of Moderate to Severe Forehead Lines in Adult PForehead Linescompleted150
2026-04-05P2Lisata Therapeutics, Inc. LSTANCT05712356 A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid TumorsCholangiocarcinoma; Gallbladder Cancer; Gallbladder Carcinoma; Intrahepatic Cholangiocarcinoma; Extrcompleted66
2026-04-06P3Arog Pharmaceuticals, Inc.NCT03258931 Study of Crenolanib vs Midostaurin Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed FLT3 Mutated AMLNewly Diagnosed FLT3 Mutated AMLcompleted214
2026-04-06P3Eli Lilly and Company LLYNCT05929066 A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or OverweightObesity; Overweight; Osteoarthritis, Knee; Obstructive Sleep Apneacompleted2335
2026-04-06P2CalciMedica, Inc. CALCNCT06374797 A Study of Auxora in Patients With AKI and Injurious Lung "Crosstalk"Acute Kidney Injuryterminated122
2026-04-06P3Alcon Research ALCNCT07082816 Reformulated PG324 Ophthalmic Solution for Intraocular Pressure ReductionOcular Hypertension; Open Angle Glaucomacompleted489
2026-04-07P2Evaxion Biotech A/S EVAXNCT05309421 A Single Arm Trial Evaluating the Efficacy and Safety of EVX-01 in Combination With Pembrolizumab in Adults With Unresectable or Metastatic MelanomaMelanoma Stage IV; Unresectable Melanomacompleted17
2026-04-07P3Gan & Lee Pharmaceuticals.NCT07527078 Evaluate the Efficacy and Safety of GZR33 Injection in Patients With Type 2 DiabetesType 2 Diabetes (T2DM)recruiting350
2026-04-08P2photonamic GmbH & Co. KGNCT03897491 PD L 506 for Stereotactic Interstitial Photodynamic Therapy of Newly Diagnosed Supratentorial IDH Wild-type GlioblastomaGlioblastomaterminated17
2026-04-08 est.P1/P2CelgeneNCT04882163 Study to Evaluate Tolerability of Iberdomide (CC-220) in Combination With Polatuzumab Vedotin Plus Rituximab or Tafasitamab or Rituximab Plus Chemotherapy in B-Lymphoma, B-Cellwithdrawn
2026-04-08P3Ningbo Rongan Biological Pharmaceutical Co., Ltd.NCT07028801 Clinical Trial of Freeze-dried Human Rabies Vaccine (Human Diploid Cells)Rabiescompleted3000
2026-04-09P3UCB Biopharma SRLNCT04123795 A Study to Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Children With Moderate to Severe Chronic Plaque PsoriasisModerate Chronic Plaque Psoriasis; Severe Chronic Plaque Psoriasis; Mixed Guttate/Plaque Psoriasiscompleted49
2026-04-09P1/P2Cantargia ABNCT05181462 Nadunolimab in Combination With Gemcitabine Plus Carboplatin in Patients With Advanced Triple Negative Breast Cancer.Triple Negative Breast Cancercompleted117
2026-04-09P2Merck Sharp & Dohme LLC MRKNCT05612035 Frespaciguat (MK-5475) INSIGNIA-PH-COPD: A Study of the Efficacy and Safety of Frespaciguat (an Inhaled sGC Stimulator) in Adults With PH-COPDPulmonary Hypertension; Chronic Obstructive Pulmonary Diseaseactive not recruiting129
2026-04-09P1/P2Pfizer PFENCT05896163 A Study to Learn About the Effects of Two Study Medicines (Maplirpacept [PF-07901801] And Glofitamab) When Given Together In People With Relapsed Or Refractory Diffuse Large B-Cell Lymphomaterminated40
2026-04-09P2Ono Pharmaceutical Co., Ltd.NCT06792136 A Study of ONO-1110 in Patients With Major Depressive DisorderMajor Depressive Disorder (MDDcompleted103
2026-04-09P3AgelessRxNCT07475546 Combination Gerotherapeutic Interventions for Healthspan ImprovementHealthspan Improvement; Aging; Longevitycompleted26
2026-04-09P2CSPC ZhongQi Pharmaceutical Technology Co., Ltd.NCT07814651 A Clinical Trial to Evaluate Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Octreotide Long-acting Injection in Patients With AcromegalyAcromegalycompleted78
2026-04-10P2/P3Oculis OCSNCT05066997 A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 1)Diabetic Macular Edemacompleted552
2026-04-10P3PharmaMarNCT05153239 Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung CanceRelapsed Small Cell Lung Cancercompleted705
2026-04-10P3Anthos Therapeutics, Inc.NCT05171075 A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTEVenous Thromboembolism; Deep Venous Thrombosis; Pulmonary Embolismterminated417
2026-04-10P2ITB-Med LLCNCT05669001 A Study of TCD601 in de Novo Renal Transplant RecipientsRenal Transplantationcompleted76
2026-04-10P2Reistone Biopharma Company LimitedNCT07158151 A Phase II Trial of the Safety and Efficacy of RSS0309 Ointment in Adults With Atopic DermatitisAtopic Dermatitis of Adultscompleted168
2026-04-10P2Sichuan Purity Pharmaceutical Technology Co., Ltd.NCT07193901 A Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Characteristics of (R)-Ketamine Hydrochloride Nasal Spray in Patients With Depression and Acute SuMajor Depressive Disorder (MDDcompleted98
2026-04-10P3R-Pharm International, LLCNCT07670546 Efficacy and Safety of Olokizumab in Patients With Polymyalgia Rheumatica (PROMISE)Polymyalgia Rheumaticaactive not recruiting125
2026-04-11P3Novartis Pharmaceuticals NVSNCT04889430 Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor TherapyAtypical Hemolytic Uremic Syndromecompleted34
2026-04-13P2Takeda TAKNCT02615184 A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years OldErosive Esophagitisterminated24
2026-04-13P3Chiesi Farmaceutici S.p.A.NCT03614234 Open Label Extension of 2 mg/kg Pegunigalsidase Alfa (PRX-102) Every 4 Weeks in Adult Fabry Disease PatientsFabry Diseasecompleted29
2026-04-13P3CelgeneNCT03651128 Efficacy and Safety Study of bb2121 Versus Standard Regimens in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM)Multiple Myelomacompleted386
2026-04-13P1/P2Janssen Pharmaceutical K.K.NCT04696809 A Study of Teclistamab in Japanese Participants With Relapsed or Refractory Multiple MyelomaHematologic Malignanciescompleted40
2026-04-13P2ShaperonNCT06024499 Phase 2 Trial of HY209gel in Atopic Dermatitis PatientsAtopic Dermatitis; Atopic Dermatitis Eczema; Atopic Dermatitis of Scalpcompleted210
2026-04-14P3Tanabe Pharma America, Inc.NCT06144840 INcreased Sun Exposure Without Pain In Research Participants With EPP or XLPErythropoietic Protoporphyria (EPP); X-Linked Protoporphyria (XLP)completed165
2026-04-14P2Omeros Corporation OMERNCT06209736 Safety and Efficacy Study of OMS906 in Patients With C3G and ICGNC3 Glomerulopathy; Idiopathic Immune Complex-Mediated Glomerulonephritisterminated3
2026-04-14 est.P3CSPC ZhongQi Pharmaceutical Technology Co., Ltd.NCT06492941 A Study of Docetaxel for Injection (Albumin Bound) in Patients With Advanced Pancreatic CancerAdvanced Pancreatic Cancernot yet recruiting142
2026-04-14P2LimmaTech Biologics AGNCT06615375 A Human Challenge Study to Assess Protection of a Shigella Tetravalent Bioconjugate VaccineShigellosiscompleted97
2026-04-14P3Inventera Inc.NCT07057037 Phase 3 Study of the Efficacy and Safety of MR Arthrography Using the NEMO-103 Injection in Patients With Known or Suspected Shoulder Joint DiseasesRotator Cuff Tear; Labral Tear; Rotator Cuff Tendinosis; Rotator Cuff Tendonitis; Articular Cartilagcompleted85
2026-04-14P2Reinovax Biologics Co., LTDNCT07333352 PCV24 Clinical Trial in Infants and Young Children Aged 2 Months (Minimum 6 Weeks) to 71 MonthsPneumococcal Infectious Diseasecompleted480
2026-04-15P3ViiV HealthcareNCT05979311 A Study to Evaluate the Efficacy, Safety, and Tolerability of Using an Oral Once-daily 2 Drug Regimen Compared to an Oral Once-daily 3 Drug Regimen for the TreaHIV; HIV Infectionsactive not recruiting463
2026-04-15P1/P2Respirion Pharmaceuticals Pty LtdNCT06016088 A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung InfectionCystic Fibrosis Lung; Respiratory Infections, Recurrent, Chronic; Pseudomonas Aeruginosacompleted71
2026-04-15 est.P1/P2Shanghai Refreshgene Technology Co., Ltd.NCT06141460 Safety and Efficacy of RRG001 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD)Neovascular Age-related Macular Degenerationrecruiting48
2026-04-15P2PRInnovation GmbHNCT06182085 Study to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Disease (AD)Mild Cognitive Impairment Due to Alzheimer's Disease; Alzheimer's Disease, Early Onsetcompleted304
2026-04-15P2ZYUS Life Sciences Inc.NCT06533657 Unique Treatment of Oncology Pain in Advanced CancerCancer Paincompleted11
2026-04-15P2Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT06897579 Carboplatin/Cisplatin + Etoposide + Benmelstobart Sequential Benmelstobart Combined With Anlotinib Versus Carboplatin/Cisplatin + Etoposide + Tislelizumab SequeExtensive Stage Small Cell Lung Cancerterminated40
2026-04-15P3Aardvark Therapeutics, Inc. AARDNCT07197034 The Hunger Elimination or Reduction Objective (HERO ) Open -Label Extension (OLE) TrialHyperphagia; Prader-Willi Syndrome; Hyperphagia in Prader-Willi Syndrometerminated19
2026-04-15P2Desentum OyNCT07254871 Study of DM-101PX in Adults With Birch Pollen AllergyBirch Pollen Allergycompleted97
2026-04-15P2Changchun GeneScience Pharmaceutical Co., Ltd.NCT07259564 A Study of GS3-007a for Oral Suspension in the Diagnosis of Adult Growth Hormone Deficiency (AGHD)Adult Growth Hormone Deficiency (AGHD)terminated120
2026-04-16P2Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)NCT05270668 Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7Diffuse Cutaneous Systemic Sclerosis; Interstitial Lung Diseaseactive not recruiting154
2026-04-16P2Takeda TAKNCT05714969 A Study of TAK-755 (rADAMTS13) With Little to No Plasma Exchange (PEX) Treatment in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)Thrombotic Thrombocytopenic Purpura (TTP)completed29
2026-04-16P3Eli Lilly and Company LLYNCT05882045 A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular DiseaseObesity; Cardiovascular Diseasescompleted1946
2026-04-16P3HTA Co., Ltd.NCT06011304 Study of 18F-Florastamin PET/CT Imaging in Patients With at Least Intermediate Risk Prostate CancerProstate Cancercompleted287
2026-04-16P3CelltrionNCT06571591 Efficacy and Safety of Pioglitazone Combination Therapy in Type 2 Diabetes Patients on a Background of Empagliflozin With MetforminT2DMcompleted606
2026-04-16P1/P2Sanofi SNYNCT06695117 Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and High-Dose InactCOVID-19 Immunization; Influenza Immunizationcompleted980
2026-04-16P2Salubris Biotherapeutics IncNCT07221513 Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary HypertensionHFrEF - Heart Failure With Reduced Ejection Fraction; HFpEF - Heart Failure With Preserved Ejection withdrawn
2026-04-17P3Baxalta now part of ShireNCT02932618 A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)Von Willebrand Diseasecompleted47
2026-04-17P3AbbVie ABBVNCT04379050 Extension Study To Evaluate Safety And Tolerability Of 24-Hour Daily Exposure Of Continuous Subcutaneous Infusion of ABBV-951 In Adult Participants With ParkinsParkinson's Disease (PD)completed130
2026-04-17P3AstraZeneca AZNNCT06502366 A Study to Investigate the Effect on Lung Function of BDA Formulated With a Next Generation Propellant Compared With an Approved Asthma Treatment (BDA With HFA Asthmacompleted424
2026-04-17P3Amgen AMGNNCT06527404 A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo NodularisPrurigo Nodularisterminated469
2026-04-17P3Gilead Sciences GILDNCT06630286 Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People With HIV-HIV-1-infectionactive not recruiting609
2026-04-17P3Shanghai Haiyan Pharmaceutical Technology Co., Ltd.NCT06890533 A Study of YZJ-4729 Tartrate Injection for the Treatment of Pain After Abdominal SurgeryPainactive not recruiting560
2026-04-17P3Shandong Suncadia Medicine Co., Ltd.NCT06904105 A Trial of HRS-7535 Tablets in Subjects With Overweight or ObesityOverweight; Obesitycompleted556
2026-04-18 est.P1/P2Novadip BiosciencesNCT05961956 Study With NVDX3 for Treatment of Low Grade Degenerative Lumbar SpondylolisthesisDegenerative Lumbar Spondylolisthesisactive not recruiting5
2026-04-18P2MBX Biosciences MBXNCT07029412 Study to Evaluate Efficacy and Dose Response of Imapextide (STEADI)Postbariatric Hypoglycemiacompleted20
2026-04-18P3Shanghai Shengdi Pharmaceutical Co., LtdNCT07275723 A Study of a Gadolinium-Based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Body Parts (Non-CentralFor Contrast-enhanced Magnetic Resonance Imaging (MRI) of Abnormal Vascular Lesions in Body Regions completed309
2026-04-20P1/P2BioMarin Pharmaceutical BMRNNCT04684940 Safety, Tolerability, and Efficacy Study of Valoctocogene Roxaparvovec in Hemophilia A With Active or Prior InhibitorsHemophilia A With Inhibitor; Hemophilia A With Anti Factor VIIIcompleted10
2026-04-20P1/P2Elicio Therapeutics ELTXNCT05726864 A Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid TumorsPancreatic Ductal Adenocarcinoma; Colorectal Cancer; KRAS G12D; KRAS G12R; KRAS G12V; KRAS G12A; KRAactive not recruiting158
2026-04-20P1/P2AkesoNCT06586294 A Study of Anti-PD-1 and LAG-3 Bispecific Antibody(AK129) Combined With Chemotherapy With or Without Cadonilimab in the First-line Treatment of Unresectable LocGastric Adenocarcinoma; Gastroesophageal Junction Adenocarcinomacompleted35
2026-04-20P2BeBetter Med IncNCT06685796 A Study of BEBT-209 in Combination With Chemotherapy for the Treatment of Advanced Triple-Negative Breast CancerAdvanced Triple-Negative Breast Cancercompleted65
2026-04-20 est.P3Beijing VDJBio Co., LTD.NCT06726096 Phase III Trial of VDJ001 In Patients With Moderate-to-severe Active Rheumatoid ArthritisRheumatoid Arthritis (RA); Anti IL-6Renrolling by invitation615
2026-04-20P2Beijing Keymed Biosciences Co., Ltd.NCT06930612 A Study of CM512 in Patients With Chronic Rhinosinusitis With Nasal Polyposis (NEZHA-1)Chronic Rhinosinusitis With Nasal Polyposiscompleted120
2026-04-20P1/P2Accro Bioscience (Suzhou) LimitedNCT07083193 A Study of AC-101 Tablets in Participants With Moderate to Severe Active Ulcerative ColitisUlcerative Colitiscompleted25
2026-04-20 est.P2Beijing Tide Pharmaceutical Co., LtdNCT07123402 To Evaluate the Efficacy and Safety of TRD205 Tablets in the Treatment of Chronic Postoperative NeuralgiaChronic Postoperative Neuralgiaenrolling by invitation184
2026-04-21P2Hutchison Medipharma LimitedNCT04923932 Savolitinib for Treating Gastric Cancer and Esophagogastric Junction Adenocarcinoma PatientsGastric Cancer; Esophagogastric Junction Disordercompleted110
2026-04-21P3Novo Nordisk A/S NVONCT05135559 A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without InhibitorsHaemophilia A and B With and Without Inhibitorsactive not recruiting153
2026-04-21P2Merck Sharp & Dohme LLC MRKNCT05144841 A Study to Evaluate Zilovertamab Vedotin (MK-2140) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) (MK-2140-004)Relapsed or Refractory Diffuse Large B-Cell Lymphomacompleted140
2026-04-21P3Lantheus Germany GmbH LNTHNCT05184088 Efficacy of [18F]Florbetaben PET for Diagnosis of Cardiac AL AmyloidosisCardiac Amyloidosis; AL Amyloidosis; ATTR Amyloidosiscompleted244
2026-04-21P3Hansa Biopharma ABNCT05369975 Efficacy and Safety in Imlifidase Desensitized Kidney Tx Patients, Including Two Non-Comparative Reference CohortsKidney Transplantation in Highly Sensitized Patientscompleted113
2026-04-21P1/P2Vertex Pharmaceuticals Incorporated VERXNCT05668741 A Phase 1/2 Study of VX-522 in Participants With Cystic Fibrosis (CF)Cystic Fibrosiscompleted26
2026-04-21P3VistaGen Therapeutics, Inc. VTGNNCT06615557 Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)Social Anxiety Disorder (SAD)completed238
2026-04-21P2AstraZeneca AZNNCT06897748 A Study to Investigate Efficacy and Safety of Tozorakimab Injections Compared With Placebo in Adult Participants With Symptomatic Chronic Obstructive Pulmonary Chronic Obstructive Pulmonary Disease (COPD)completed98
2026-04-21P3SandozNCT07223294 Study to Evaluate the Therapeutic Equivalence and Safety of Fluticasone Furoate and Vilanterol Inhalation Powder 100 mcg/25 mcg and BREO ELLIPTA 100 mcg/25 mcg Respiratorywithdrawn
2026-04-21P2Guangdong Hengrui Pharmaceutical Co., LtdNCT07233655 A Phase II Trial of SHR-3045 Injection in Patients With Rheumatoid ArthritisModerate to Severe Active Rheumatoid Arthritisactive not recruiting30
2026-04-22P3Novo Nordisk A/S NVONCT06388187 A Research Study to See How Well Different Doses of CagriSema Help People With Excess Body Weight Lose WeightObesitycompleted300
2026-04-22P2Jiangsu HengRui Medicine Co., Ltd.NCT06688123 Efficacy and Safety of SHR-3167 and Insulin Glargine in Type 2 Diabetes SubjectsType 2 Diabetescompleted275
2026-04-22P3Viridian Therapeutics, Inc. VRDNNCT06812325 A Safety and Tolerability Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)Thyroid Eye Disease (TED)active not recruiting320
2026-04-22P2Autobahn Therapeutics, Inc.NCT06869187 Study of ABX-002 for the Adjunctive Treatment of Depressive Episodes Associated With Bipolar Disorder in AdultsBipolar Disorder Depressionactive not recruiting35
2026-04-22P3Takeda TAKNCT06973291 A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque PsoriasisPlaque Psoriasiscompleted606
2026-04-22P3Otsuka Pharmaceutical Development & Commercialization, Inc.NCT06973577 P3b Short-term Study of CTN in Patients With ADHD and Comorbid AnxietyADHD; Anxiety; Generalized Anxiety; Social Anxiety Disordercompleted315
2026-04-23P3Almirall, S.A.NCT05916365 Long-term Safety and Efficacy of Lebrikizumab in Adult and Adolescent Participant With Moderate-to-Severe Atopic DermatitisAtopic Dermatitiscompleted174
2026-04-23P3BioMarin Pharmaceutical BMRNNCT06455059 Interventional Study of Vosoritide for the Treatment of Children With HypochondroplasiaHypochondroplasiacompleted81
2026-04-23P3Gilead Sciences GILDNCT06630299 Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1HIV-1-Infectionactive not recruiting600
2026-04-23P2Radiopharm Theranostics, Ltd RADXNCT06777433 Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain MetastasesBrain Metastases From Solid Tumorsactive not recruiting30
2026-04-23 est.P2Haisco Pharmaceutical Group Co., Ltd.NCT06820749 A Study to Evaluate the Efficacy and Safety of HSK31858 Tablets in Patients with Airway Mucus HypersecretionAsthma Bronchiale; Bronchiectasis; Chronic Obstructive Pulmonary Disease (COPD)enrolling by invitation309
2026-04-23P1/P2Werewolf Therapeutics, Inc. HOWLNCT06939283 A Phase 1b/2 Multisite Dose-finding and Expansion Study of WTX-330 in Adult Patients With Selected Advanced or Metastatic Solid Tumors or LymphomaAdvanced or Metastatic Solid Tumors; Non-Hodgkin Lymphomacompleted24
2026-04-23P2Inimmune CorporationNCT07556393 Environmental Exposure Unit Trial in Subjects With Ragweed-induced Allergic RhinitisAllergic Rhinitis Due to Allergens; Rhinitis Allergic; Allergic Rhinitiscompleted78
2026-04-23P2Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.NCT07634744 A Phase IIa Study in Primary IgA Nephropathy PatientsIgA Nephropathycompleted25
2026-04-24P3Merck Sharp & Dohme LLC MRKNCT04895358 Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3Breast Neoplasmsactive not recruiting342
2026-04-24P3Otsuka Pharmaceutical Development & Commercialization, Inc.NCT05279313 A Trial of Centanafadine Long-term Safety in Children and Adolescents With Attention-deficit/Hyperactivity Disorder.Attention Deficit/Hyperactivity Disordercompleted680
2026-04-24P3Mabwell (Shanghai) Bioscience Co., Ltd.NCT06804590 A Study on Efficacy, Safety and Immunogenicity of 9MW0311 in Postmenopausal Women With OsteoporosisPostmenopausal Women Osteoporosiscompleted280
2026-04-24P2Chengdu Kanghong Pharmaceutical Group Co., Ltd.NCT07096791 A Phase 2 Study to Evaluate Efficacy and Safety of KH607 Tablets in Woman With Postpartum DepressionPostpartum Depressive Disordercompleted72
2026-04-25P2ST Pharm Co., Ltd.NCT05869643 A Clinical Trial of STP0404 in Adults With HIV-1 InfectionHIV-1-infectioncompleted25
2026-04-25P3Natureceuticals Sdn BhdNCT07669506 A Study to Evaluate the Efficacy and Safety of Orally Administered Extract of Orthosiphon Stamineus (NuvastaticTM-C5OSEW5050ESA) in Patient With Breast Cancer UBreast Neoplasms; Fatigue; Quality of Life; Chemotherapy, Adjuvantcompleted180
2026-04-26 est.P2WinSanTor, IncNCT05488873 A Study of Topical Pirenzepine or Placebo in Oncology Patients With Chemotherapy Induced Peripheral NeuropathyChemotherapy-induced Peripheral Neuropathyunknown60
2026-04-27P3BeOne Medicines ONCNCT04002297 A Study to Investigate the Efficacy of Zanubrutinib Plus Rituximab Compared With Bendamustine Plus Rituximab in Adults With Previously Untreated Mantle Cell LymMantle Cell Lymphoma; Non-Hodgkin Lymphomaactive not recruiting510
2026-04-27P3AbbVie ABBVNCT04750226 Study To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In Adult Participants With Advanced ParkinParkinson's Disease (PD)completed118
2026-04-27 est.P2CNS Pharmaceuticals, Inc. CNSPNCT04762069 A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma MultiformeGlioblastoma Multiforme, Adultactive not recruiting252
2026-04-27P2Agenus Inc. AGENNCT05529316 A Study of Botensilimab (AGEN1181) for the Treatment of Advanced MelanomaAdvanced Melanomaterminated150
2026-04-27P2JemincareNCT06670534 A Dose-finding Study of JMKX003142 in Treatment of Renal EdemaEdema Secondary; Edema Legcompleted133
2026-04-28P3Abivax S.A. ABVXNCT05535946 ABTECT - MaintenanceUlcerative Colitisactive not recruiting1116
2026-04-28 est.P2Hansoh BioMedical R&D CompanyNCT06176508 Efficacy and Safety of HS-10374 Compared to Placebo in Adults With Active Psoriatic ArthritisPsoriatic Arthritisunknown160
2026-04-28P2Amgen AMGNNCT06312020 A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's SyndromeSjogren's Syndrometerminated209
2026-04-28P2Hoffmann-La RocheNCT07081958 A Study Evaluating the Effect of Daily Oral Tifeglipron (RO7795081) in Participants With Obesity or Overweight With at Least One Weight-Related ComorbidityObesity or Overweightcompleted352
2026-04-28P2Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT07252908 A Phase II Clinical Trial on the Efficacy and Safety of TQC3721 Inhalation PowderPulmonary Disease, Chronic Obstructivecompleted195
2026-04-28P2Jiangsu Aosaikang Pharmaceutical Co., Ltd.NCT07742852 ASKC200 for Knee Osteoarthritis PainOsteoarthritis (OA) of the Knee; Painactive not recruiting175
2026-04-29P3Cerus Corporation CERSNCT03037164 INTERCEPT Blood System for RBCs Study in Regions at Potential Risk for Zika Virus Transfusion-Transmitted InfectionsAnemiacompleted692
2026-04-29 est.P3Ocular Therapeutix, Inc. OCULNCT06223958 Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (Axitinib Implant) in Subjects With Neovascular Age-Related Macular DegenNeovascular Age-Related Macular Degenerationactive not recruiting344
2026-04-29P2Ribocure Pharmaceuticals ABNCT06717074 A Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of RBD4059 in Participants With Stable Coronary Artery DiseaseStable Coronary Artery Disease CADcompleted30
2026-04-29P3Colgate Palmolive CLNCT07398846 Efficacy of a Stannous Fluoride Toothpaste, Cetylpyridinium Chloride Mouthwash, and Battery Toothbrush Regimen in Reducing Established Dental Plaque and GingiviPlaquecompleted134
2026-04-30P3Hoffmann-La RocheNCT03274492 A Study Comparing the Efficacy and Safety of Polatuzumab Vedotin With Rituximab-Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab-CyclophosDiffuse Large B-Cell Lymphomacompleted1000
2026-04-30P3Zealand Pharma ZEAL.CONCT03905707 Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBSShort Bowel Syndromecompleted150
2026-04-30P3Zealand Pharma ZEAL.CONCT04881825 Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Extension TrialShort Bowel Syndromecompleted84
2026-04-30P1/P2Cantex PharmaceuticalsNCT05635734 Azeliragon and Chemoradiotherapy in Newly Diagnosed GlioblastomaGlioblastomacompleted33
2026-04-30P2/P3Immutep S.A.S. IMMPNCT05747794 Study in Metastatic Breast Cancer Patients Receiving Eftilagimod Alpha or Placebo in Combination With Paclitaxel ChemotherapyBreast Carcinomaterminated72
2026-04-30 est.P3Shenzhen TargetRx Co., Ltd.NCT06082635 TGRX-326 Chinese Phase III for Advanced Non-small Cell Lung Cancer (NSCLC)Non Small Cell Lung Canceractive not recruiting321
2026-04-30 est.P2OncotherapeuticsNCT06115135 A Study of Venetoclax in Combination With Isatuximab and Dexamethasone for Relapsed/Refractory Multiple MyelomaMultiple Myeloma in Relapse; Multiple Myeloma, Refractoryrecruiting39
2026-04-30 est.P1/P2Multitude Therapeutics Inc.NCT06209580 AMT-253 in Patients With Advanced Solid TumoursMalignant Melanoma; Advanced Solid Tumorsrecruiting96
2026-04-30P2AstraZeneca AZNNCT06450197 Phase IIa Study Evaluating AZD7798 in Crohn's DiseaseModerate to Severe Crohn's Diseaseactive not recruiting120
2026-04-30 est.P1/P2Shanghai Hengrui Pharmaceutical Co., Ltd.NCT06589778 A Study of SHR-A2102 in Combination With Adebrelimab and SHR-8068 in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung CancerNon-Small Cell Lung Cancerunknown124
2026-04-30 est.P3Tasly Pharmaceutical Group Co., LtdNCT06685978 Efficacy and Safety of Xiangjurupining Capsule for Hyperplasia of Mammary GlandsHyperplasia of Mammary Glandsrecruiting430
2026-04-30 est.P3Wuhan Createrna Science and Technology Co., LtdNCT06716970 QR12000 Compound Tablets in Patients with Moderate to Severe Essential HypertensionEssential Hypertensionnot yet recruiting810
2026-04-30 est.P2Tiziana Life Sciences LTD TLSANCT06890923 Nasal Foralumab in Patients With Non-Active Secondary Progressive Multiple SclerosisNon-Active Secondary Progressive Multiple Sclerosisrecruiting55
2026-04-30 est.P2Centessa Pharmaceuticals (UK) LimitedNCT07096674 A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic HypersomniaNarcolepsy Type 1; Narcolepsy Type 2; Idiopathic Hypersomniarecruiting90
2026-04-30 est.P3Genrix (Shanghai) Biopharmaceutical Co., Ltd.NCT07154342 A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic RhinitisAllergic Rhinitis, Seasonalrecruiting150

← 2026-03 | 2026-05 →

Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA (openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score. Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP readout_calendar / fda_decisions. Not investment advice.